Works by Secreto, Charla

Results: 13

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00477-5

By:

Wang, Yucai;
Sinha, Sutapa;
Wellik, Linda E.;
Secreto, Charla R.;
Rech, Karen L.;
Call, Timothy G.;
Parikh, Sameer A.;
Kenderian, Saad S.;
Muchtar, Eli;
Hayman, Suzanne R.;
Koehler, Amber B.;
Van Dyke, Daniel L.;
Leis, Jose F.;
Slager, Susan L.;
Dong, Haidong;
Kay, Neil E.;
He, Rong;
Ding, Wei

Publication type:

Article

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance.

Published in:

2021

By:

Sinha, Sutapa;
Secreto, Charla R.;
Boysen, Justin C.;
Lesnick, Connie;
Wang, Zhiquan;
Ding, Wei;
Call, Timothy G.;
Kenderian, Saad J.;
Parikh, Sameer A.;
Warner, Steven L.;
Bearss, David J.;
Ghosh, Asish K.;
Kay, Neil E.

Publication type:

Letter

Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells.

Published in:

Leukemia & Lymphoma, 2016, v. 57, n. 10, p. 2409, doi. 10.3109/10428194.2016.1161186

By:

Kay, Neil E.;
Sassoon, Traci;
Secreto, Charla;
Sinha, Sutapa;
Shanafelt, Tait D.;
Ghosh, Asish K.;
Arbiser, Jack L.

Publication type:

Article

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

Published in:

American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762

By:

Larsen, Jeremy T.;
Shanafelt, Tait D.;
Leis, Jose F.;
LaPlant, Betsy;
Call, Tim;
Pettinger, Adam;
Hanson, Curtis;
Erlichman, Charles;
Habermann, Thomas Matthew;
Reeder, Craig;
Nikcevich, Daniel;
Bowen, Deborah;
Conte, Michael;
Boysen, Justin;
Secreto, Charla;
Lesnick, Connie;
Tschumper, Renee;
Jelinek, Diane;
Kay, Neil E.;
Ding, Wei

Publication type:

Article

Clonal dynamics of Richter transformation in chronic lymphocytic leukemia.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3282

By:

Wang, Hanyin;
Tian, Shulan;
Secreto, Charla R.;
Sinha, Sutapa;
Shi, Min;
Call, Timothy;
Wang, Yucai;
Parikh, Sameer A.;
Kenderian, Saad S.;
He, Rong;
Leis, Jose F.;
VanDyke, Daniel L.;
Klee, Eric W.;
Slager, Susan L.;
Braggio, Esteban;
Yan, Huihuang;
Ding, Wei

Publication type:

Article

Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome.

Published in:

Hematological Oncology, 2022, v. 40, n. 2, p. 302, doi. 10.1002/hon.2950

By:

Wang, Hanyin;
Tian, Shulan;
Zhao, Qing;
Blumenschein, Wendy;
Yearley, Jennifer H.;
Secreto, Charla R.;
Sinha, Sutapa;
Call, Timothy G.;
Wang, Yucai;
Parikh, Sameer A.;
Kenderian, Saad S.;
He, Rong;
Leis, Jose F.;
Shi, Min;
Van Dyke, Daniel L.;
Kay, Neil E.;
Slager, Susan L.;
Braggio, Esteban;
Yan, Huihuang;
Ding, Wei

Publication type:

Article

Correction: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis.

Published in:

2013

By:

Mukherjee, Priyabrata;
Bhattacharya, Resham;
Bone, Nancy;
Lee, Yean K.;
Ranjan Patra, Chitta;
Shanfeng Wang;
Lichun Lu;
Secreto, Charla;
Banerjee, Pataki C.;
Yaszemski, Michael J.;
Kay, Neil E.;
Mukhopadhyay, Debabrata

Publication type:

Correction Notice

Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis.

Published in:

Journal of Nanobiotechnology, 2007, v. 5, p. 4, doi. 10.1186/1477-3155-5-4

By:

Mukherjee, Priyabrata;
Bhattacharya, Resham;
Bone, Nancy;
Lee, Yean K.;
Patra, Chitta Ranjan;
Shanfeng Wang;
Lichun Lu;
Secreto, Charla;
Banerjee, Pataki C.;
Yaszemski, Michael J.;
Kay, Neil E.;
Mukhopadhyay, Debabrata

Publication type:

Article

Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2015, v. 169, n. 3, p. 445, doi. 10.1111/bjh.13211

By:

Ojha, Juhi;
Secreto, Charla R.;
Rabe, Kari G.;
Van Dyke, Daniel L.;
Kortum, Klaus M.;
Slager, Susan L.;
Shanafelt, Tait D.;
Fonseca, Rafael;
Kay, Neil E.;
Braggio, Esteban

Publication type:

Article

Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis.

Published in:

British Journal of Haematology, 2014, v. 164, n. 1, p. 146, doi. 10.1111/bjh.12564

By:

Ding, Wei;
Shanafelt, Tait D.;
Lesnick, Connie E.;
Erlichman, Charles;
Leis, Jose F.;
Secreto, Charla;
Sassoon, Traci R.;
Call, Timothy G.;
Bowen, Deborah A.;
Conte, Michael;
Kumar, Shaji;
Kay, Neil E.

Publication type:

Article

Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.

Published in:

2008

By:

Zent, Clive S.;
Call, Timothy G.;
Shanatelt, Tait D.;
Tschumper, Renee C.;
Jelinek, Diane F.;
Bowen, Deborah A.;
Secreto, Charla R.;
LaPlant, Betsy R.;
Kabat, Brian F.;
Kay, Neil E.;
Shanafelt, Tait D

Publication type:

journal article

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.

Published in:

British Journal of Haematology, 2009, v. 147, n. 4, p. 471, doi. 10.1111/j.1365-2141.2009.07868.x

By:

Ding, Wei;
Nowakowski, Grzegorz S.;
Knox, Traci R.;
Boysen, Justin C.;
Maas, Mary L.;
Schwager, Susan M.;
Wu, Wenting;
Wellik, Linda E.;
Dietz, Allan B.;
Ghosh, Asish K.;
Secreto, Charla R.;
Medina, Kay L.;
Shanafelt, Tait D.;
Zent, Clive S.;
Call, Timothy G.;
Kay, Neil E.

Publication type:

Article

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.

Published in:

British Journal of Haematology, 2009, v. 146, n. 6, p. 660, doi. 10.1111/j.1365-2141.2009.07811.x

By:

Shanafelt, Tait D.;
Byrd, John C.;
LaPlant, Betsy;
Zent, Clive S.;
Call, Tim;
Secreto, Charla;
Grever, Michael R.;
Lin, Thomas S.;
Kay, Neil E.

Publication type:

Article